Early research (Phase 1)Ended earlyNCT01010542What this trial is testingStudy Evaluating Single Dose Of ILV-095 In Psoriasis SubjectsWho this might be right forPlaque Psoriasis Pfizer 39
Large-scale testing (Phase 3)Study completedNCT03611751What this trial is testingAn Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPsoriasis Bristol-Myers Squibb 1,020
Post-approval studies (Phase 4)WithdrawnNCT05499416What this trial is testingEffect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic ArthritisWho this might be right forPsoriasis VulgarisActive Psoriatic Arthritis Innovaderm Research Inc.
Large-scale testing (Phase 3)Study completedNCT02207231What this trial is testingGuselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisWho this might be right forPsoriasis Janssen Research & Development, LLC 837
Large-scale testing (Phase 3)Study completedNCT02207244What this trial is testingGuselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and RetreatmentWho this might be right forPsoriasis Janssen Research & Development, LLC 992
Large-scale testing (Phase 3)Study completedNCT01550744What this trial is testingUstekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque PsoriasisWho this might be right forPsoriasis Janssen Biotech, Inc. 478
Very early researchStudy completedNCT05282771What this trial is testingA Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.Who this might be right forPlaque Psoriasis Sun Pharmaceutical Industries, Inc. 402
Large-scale testing (Phase 3)Active Not RecruitingNCT06934226What this trial is testingAssess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Janssen Research & Development, LLC 752
Testing effectiveness (Phase 2)Study completedNCT00428974What this trial is testingSafety and Efficacy Study of CF101 to Treat PsoriasisWho this might be right forPlaque Psoriasis Can-Fite BioPharma 76
Testing effectiveness (Phase 2)Study completedNCT01483599What this trial is testingEvaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Janssen Inc. 293
Large-scale testing (Phase 3)Study completedNCT03210259What this trial is testingThe VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque PsoriasisWho this might be right forPsoriasis Boehringer Ingelheim 259
Testing effectiveness (Phase 2)Study completedNCT00147329What this trial is testingSafety and Efficacy Study of MM-093 in Patients With Chronic Plaque PsoriasisWho this might be right forPsoriasis Merrimack Pharmaceuticals 30
Large-scale testing (Phase 3)Study completedNCT02387801What this trial is testingThe Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe PsoriasisWho this might be right forPsoriasis Eli Lilly and Company 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04862286What this trial is testingStudy to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977Who this might be right forPsoriasis AbbVie 132
Testing effectiveness (Phase 2)Study completedNCT01914627What this trial is testingParallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis CapitisWho this might be right forScalp Psoriasis G. Pohl-Boskamp GmbH & Co. KG 90
Large-scale testing (Phase 3)Study completedNCT05763082What this trial is testingBioequivalence Study of Two Treatments for the Treatment of Plaque PsoriasisWho this might be right forPlaque Psoriasis Padagis LLC 416
Large-scale testing (Phase 3)Study completedNCT04673786What this trial is testingCompare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque PsoriasisWho this might be right forPsoriasis Celltrion 509
Large-scale testing (Phase 3)Study completedNCT03370133What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis UCB Biopharma SRL 567
Large-scale testing (Phase 3)Study completedNCT02346240What this trial is testingEfficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)Who this might be right forPsoriasisPlaque Psoriasis UCB Biopharma S.P.R.L. 559
Post-approval studies (Phase 4)Study completedNCT00663052What this trial is testingStudy Evaluating Etanercept for the Treatment of Moderate to Severe PsoriasisWho this might be right forPlaque PsoriasisPsoriasis Pfizer 273